Mycobacterium infection, the causative agent of infection (TB), is classified as a risk group 3 power, which calls for a Biosafety Level 3 lab (BSL-3) for culture, drug susceptibility experiment, and other lab examinations. Access to a safety laboratory endure be restricted to staff appendages and accredited callers. M. tuberculosis can cause laboratory-seized infections. To guarantee adequate infection control, it is important that a comprehensive and strict biosafety tactics is developed and trailed. Such a policy includes patterned rules and regulations for containment, individual protective supplies (PPE), standard operating procedures (SOP) for different workshop tasks, and a transparent structure for managing safe occupied conditions in diagnostic TB workshops. It is well documented that M. tuberculosis can cause lab-acquired contaminations, and the risk of TB among healthcare workers is usually higher than in the general public. M. tuberculosis even looks in the top-ten list of hazardous agents for lab staff. However, the beginning of the TB infection can only be traced to a distinguishing laboratory accident in a youth of cases. The most important route for lab-acquired infections is aerosols. Thus, contamination control efforts need to focus on restricting the generation of aerosols all along laboratory work, for example, through dependable centrifugation and pipetting. For effective infection control, it is critical that a comprehensive and scrupulous biosafety policy is developed, recognized, and followed by the lab staff. The procedure should include patterned rules and regulations for limit; personal protective supplies (PPE); practical training; standard operating processes (SOPs) for all the different workshop tasks, and transparent and clearly defined levels of maturity for establishing and maintaining secure working environments in the diagnostic TB laboratory.
Author(s) Details:
P. Suganthi,
Department of Medical Microbiology, Institute of
Basic Medical Sciences, University of Madras, Tharamani Campus, Chennai, Tamil
Nadu, India.
B.
Usharani,
Department
of Biomedical Genetics, Institute of Basic Medical Sciences, University of
Madras, Tharamani Campus, Chennai, Tamil Nadu, India.
R. Venkateswari,
Department of Medical Biochemistry, Institute of Basic Medical Sciences,
University of Madras, Tharamani Campus, Chennai, Tamil Nadu, India.
M. Muthuraj,
State TB Training and Demonstration Centre, Intermediate Reference
Laboratory, Government Hospital for Chest Diseases, Puducherry, India.
Please see the link here: https://stm.bookpi.org/RAMB-V3/article/view/9759
No comments:
Post a Comment